(Q37612176)

21 August 2017

1 reference

title

Androgen deficiency and atherosclerosis: The lipid link (English)

1 reference

21 August 2017

1 reference

1 reference

Abdulmaged M Traish

1

1 reference

21 August 2017

Rami Abdou

series ordinal

2

1 reference

21 August 2017

Kyriakos E Kypreos

series ordinal

3

1 reference

21 August 2017

publication date

6 October 2009

1 reference

21 August 2017

published in

Vascular Pharmacology

1 reference

21 August 2017

volume

51

1 reference

21 August 2017

issue

5-6

1 reference

21 August 2017

page(s)

303-313

1 reference

Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Low testosterone level is an independent determinant of endothelial dysfunction in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Impact of androgen deprivation therapy on cardiovascular disease and diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone making an entry into the cardiometabolic world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Contribution of age and declining androgen levels to features of the metabolic syndrome in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgens and body fat distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Antiandrogenic therapy can cause coronary arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The inverse relationship between thoracic aortic intima media thickness and testosterone level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Adipose tissue, adipokines, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Recycling of apolipoprotein E in mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Type 2 diabetes and cardiovascular disease: getting to the fat of the matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The dysmetabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Insulin resistance and the metabolic syndrome-a challenge of the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Advances in the management of testosterone deficiency. Introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone and atherosclerosis in aging men: purported association and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deficiency, diabetes, and the metabolic syndrome in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The decline of androgen levels in elderly men and its clinical and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

LDL receptor deficiency or apoE mutations prevent remnant clearance and induce hypertriglyceridemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for ef

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Increased carotid atherosclerosis in andropausal middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone as a protective factor against atherosclerosis--immunomodulation and influence upon plaque development and stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Testosterone and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The influence of androgen deprivation therapy on metabolism in patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The association of hypotestosteronemia with coronary artery disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Cardiovascular effects of androgen depletion and replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

High-density lipoproteins and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Low testosterone levels are associated with coronary artery disease in male patients with angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Metabolic complications of androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Changes in body composition during androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Insulin sensitivity during combined androgen blockade for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Antiatherogenic functionality of high density lipoprotein: how much versus how good

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Association between lipid profile and circulating concentrations of estrogens in young men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The dark side of testosterone deficiency: III. Cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Endogenous hormones and carotid atherosclerosis in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Role of endothelial cells and their products in the modification of low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgens and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

The CAG repeat polymorphism within the androgen receptor gene and maleness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.09.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2009.09.003

1 reference

21 August 2017

1 reference